Summary
Patients with type 2 diabetes mellitus (T2DM) exhibit hyperglycemia and hyperinsulinemia and increased risk of fracture at early stage, but they were found to have normal or even enhanced bone mineral density (BMD). This study was aimed to examine the molecular mechanisms governing changes in bone structure and integrity under both hyperglycemic and hyperinsulinemic conditions. Monocytes were isolated from the bone marrow of the C57BL/6 mice, induced to differentiate into osteoclasts by receptor activator of nuclear factor kappa-B ligand (RANKL) and macrophage colony-stimulating factor (M-CSF) and exposed to high glucose (33.6 mmol/L), high insulin (1 μmol/L), or a combination of high glucose/high insulin (33.6 mmol/L glucose and 1 μmol/L insulin). Cells cultured in α-MEM alone served as control. After four days of incubation, the cells were harvested and stained for tartrate resistant acid phosphatase (TRAP). Osteoclast-related genes including RANK, cathepsin K and TRAP were determined by using real-time PCR. The resorptive activity of osteoclasts was measured by using a pit formation assay. Osteoclasts that were derived from monocytes were of multinucleated nature and positive for TRAP, a characteristic marker of osteoclasts. Cell counting showed that the number of osteoclasts was much less in high glucose and high glucose/high insulin groups than in normal glucose and high insulin groups. The expression levels of RANK and cathepsin K were significantly decreased in high glucose, high insulin and high glucose/high insulin groups as compared with normal glucose group, and the TRAP activity was substantially inhibited in high glucose environment. The pit formation assay revealed that the resorptive activity of osteoclasts was obviously decreased in high glucose group and high glucose/high insulin group as compared with normal group. It was concluded that osteoclastogenesis is suppressed under hyperglycemic and hyperinsulinemic conditions, suggesting a disruption of the bone metabolism in diabetic patients.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Rosen P, Nawroth PP, King G, et al. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev, 2001,17(3):189–212
Yaturu S. Diabetes and skeletal health. J Diabetes, 2009,1(4):246–254
Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis. Osteoporos Int, 2007,18(4):427–444
Hamann C, Goettsch C, Mettelsiefen J, et al. Delayed bone regeneration and low bone mass in a rat model of insulin-resistant type 2 diabetes mellitus is due to impaired osteoblast function. Am J Physiol Endocrinol Metab, 2011,301(6):E1220–1228
Okazaki R, Miura M, Toriumi M, et al. Short-term treatment with troglitazone decreases bone turnover in patients with type 2 diabetes mellitus. Endocr J, 1999,46(6):795–801
Shockley KR, Lazarenko OP, Czernik PJ, et al. PPARgamma2 nuclear receptor controls multiple regulatory pathways of osteoblast differentiation from marrow mesenchymal stem cells. J Cell Biochem, 2009,106(2): 232–246
Hie M, Iitsuka N, Otsuka T, et al. Insulin-dependent diabetes mellitus decreases osteoblastogenesis associated with the inhibition of Wnt signaling through increased expression of Sost and Dkk1 and inhibition of Akt activation. Int J Mol Med, 2011,28(3): 455–462
Nakasato YR, Janckila AJ, Halleen JM, et al. Clinical significance of immunoassays for type-5 tartrate-resistant acid phosphatase. Clin Chem, 1999,45(12):2150–2157
Yang L, Perez-Amodio S, Barrere-de Groot FY, et al. The effects of inorganic additives to calcium phosphate on in vitro behavior of osteoblasts and osteoclasts. Biomaterials, 2010, 31(11):2976–2989
Janghorbani M, Van Dam RM, Willett WC, et al. Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol, 2007,166(5):495–505
Li Z, Kong K, Qi W. Osteoclast and its roles in calcium metabolism and bone development and remodeling. Biochem Biophys Res Commun, 2006,343(2):345–350
Raisz LG. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest, 2005,115(12):3318–3325
Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature, 2003,423(6937):337–342
Rauner M, Sipos W, Pietschmann P. Osteoimmunology. Int Arch Allergy Immunol, 2007,143(1):31–48
Sipos W, Pietschmann P, Rauner M, et al. Pathophysiology of osteoporosis. Wien Med Wochenschr, 2009,159(9–10):230–234
Gopalakrishnan V, Vignesh RC, Arunakaran J, et al. Effects of glucose and its modulation by insulin and estradiol on BMSC differentiation into osteoblastic lineages. Biochem Cell Biol, 2006,84(1):93–101
Zhen D, Chen Y, Tang X. Metformin reverses the deleterious effects of high glucose on osteoblast function. J Diabetes Complications, 2010,24(5):334–344
Freude T, Braun KF, Haug A, et al. Hyperinsulinemia reduces osteoblast activity in vitro via upregulation of TGF-beta. J Mol Med (Berl), 2012,90(11):1257–1266
Ferron M, Wei J, Yoshizawa T, et al. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell, 2010,142(2):296–308
Wittrant Y, Gorin Y, Woodruff K, et al. High d(+)glucose concentration inhibits RANKL-induced osteoclastogenesis. Bone, 2008,42(6):1122–1130
Huang S, Kaw M, Harris MT, et al. Decreased osteoclastogenesis and high bone mass in mice with impaired insulin clearance due to liver-specific inactivation to CEACAM1. Bone, 2010,46(4):1138–1145
Author information
Authors and Affiliations
Corresponding author
Additional information
This project was supported by the National Natural Science Foundation of China (No. 81070691).
Rights and permissions
About this article
Cite this article
Xu, F., Ye, Yp., Dong, Yh. et al. Inhibitory effects of high glucose/insulin environment on osteoclast formation and resorption in vitro . J. Huazhong Univ. Sci. Technol. [Med. Sci.] 33, 244–249 (2013). https://doi.org/10.1007/s11596-013-1105-z
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11596-013-1105-z